Latest News

PagSeguro Digital’s Q4 2025 and full-year 2025 results, released on March 4, 2026, showed revenue rising to R$5.40 billion for the quarter and R$20.41 billion for the year, while net income held roughly flat at R$2.12 billion. Alongside earnings, the company completed a share repurchase program totaling 17,922,208 shares, or about 6.09% of its float, for US$165.49 million, which could meaningfully affect earnings per share and ownership concentration. We’ll now examine how the completion of...

On March 12, 2026, Acadia Healthcare Company, Inc. appointed veteran healthcare finance leader Daniel Cancelmi, former Executive Vice President and Chief Financial Officer of Tenet Healthcare Corporation, to its Board of Directors, while director Wade D. Miquelon chose not to stand for re-election at the 2026 Annual Meeting. Cancelmi’s three decades of healthcare finance and operational leadership, including overseeing Tenet’s transformation and large-scale portfolio reshaping, adds deep...

AI partnership expansion with Google Cloud comes into focus Waystar Holding (WAY) is back on investor radars after announcing an expanded collaboration with Google Cloud that centers on deeper use of Gemini AI models and data infrastructure in healthcare payments. The move targets more automation across complex revenue cycle workflows, including new agentic AI use cases that combine financial and clinical data, and could influence how investors think about the company’s long term technology...

Thomas Cook (India) Limited and SOTC Travel recently announced a partnership with Booking.com to integrate over 31 million accommodation listings into their corporate booking tool, offering Indian business travellers consumer-style choice with enterprise-grade controls, GST-compliant invoicing, and India-specific servicing across more than 2,500 cities and towns. This collaboration highlights how Booking Holdings is deepening its presence in India’s corporate travel market by pairing broad...

Ituran Location and Control Ltd. recently reported higher fourth‑quarter and full‑year 2025 earnings, approved a US$1.50 per‑share cash dividend totaling about US$30.00 million to be paid on April 16, 2026, and completed a US$25.42 million share buyback while authorizing an additional US$10.00 million for repurchases. The combination of earnings growth, a sizable dividend drawn from “Preferred Income” and “Preferred Technological Income” at a reduced 20% withholding tax rate, and an expanded...

Dyne Therapeutics recently advanced its neuromuscular pipeline, initiating the global Phase 3 HARMONIA trial of z-basivarsen for myotonic dystrophy type 1 and releasing new 24‑month data from the Phase 1/2 DELIVER trial of z-rostudirsen in Duchenne muscular dystrophy, alongside reporting a full-year 2025 net loss of US$446.21 million. With FDA alignment on HARMONIA’s confirmatory design, multiple regulatory designations for both assets, and additional long-term cardiopulmonary data in DMD,...

IBM (NYSE:IBM) has introduced what it calls the industry's first quantum centric supercomputing architecture, a blueprint for combining quantum and classical systems. The company also expanded partnerships in quantum safe cybersecurity with Bain & Company and in AI infrastructure with NVIDIA. These announcements reflect IBM's focus on quantum, AI and security solutions for enterprise clients. IBM shares trade at $249.25, with the stock up 119.4% over the past 3 years and 144.0% over 5...

Lifecore Biomedical (LFCR) just posted its FY 2025 fourth quarter numbers, with revenue of US$36.4 million and a basic EPS loss of US$0.06. This sets the tone for a year where the trailing twelve months show revenue at about US$129.5 million and a basic EPS loss of US$0.92. Over recent quarters, revenue has moved from US$24.7 million in Q1 FY 2025 to US$31.1 million in Q3 and then US$36.4 million in Q4. Quarterly basic EPS losses ranged from US$0.53 in Q1 to US$0.29 in Q3 and US$0.06 in Q4,...

Why TriMas is on investors’ radar today TriMas (TRS) has drawn fresh interest as investors look at its recent share performance alongside its value score of 3 and current market capitalization of about US$1.32b. The stock shows a 1 day return of 1.23%, a month return decline of 2.21%, and a past 3 months return of 3.77%, while the 1 year total return stands at 42.54%. See our latest analysis for TriMas. The recent 1 day share price gain of 1.23% to US$35.47 comes after a weaker 7 day and year...

What Alibaba Group Holding (NYSE:BABA) offers investors right now Alibaba Group Holding (NYSE:BABA) gives you exposure to a broad ecosystem that spans e-commerce marketplaces, logistics, cloud computing, digital media, local services, healthcare, and collaboration tools across China and international markets. See our latest analysis for Alibaba Group Holding. Alibaba’s recent share price shows mixed momentum, with a 1 day share price return of 1.11% and a 7 day share price return of 3.07%,...

In March 2026, Amylyx Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a reduced net loss of US$33.0 million for the quarter and US$144.74 million for the year, alongside narrower basic losses per share, and filed new shelf registrations covering common and preferred stock, debt, warrants, and units. An interesting angle is that Amylyx paired this improvement in reported losses with fresh shelf capacity, potentially increasing its flexibility to fund pipeline and...

Investors may be wondering if Credo Technology Group Holding at around US$116.88 is still offering value after such a strong run, or if enthusiasm has already been priced in. The stock has returned 0.8% over the last week, a 3.8% decline over 30 days, an 18.4% decline year to date and a 148.6% gain over the past year, with a very large 3 year return that is well over 10x. These moves have kept Credo on the radar for investors who focus on price momentum and shifts in sentiment. Recent...

AAR Manufacturing LLC, a unit of AAR Corp. (NYSE:AIR), has been awarded a long term contract with the U.S. Department of War. The agreement covers repair of the 463L Legacy Cargo Pallet system for the U.S. Air Force through 2031. The contract extends AAR’s government services work beyond its existing commercial-focused operations. For investors watching NYSE:AIR at a current share price of $105.64, this contract adds a fresh data point to an already strong share price run, with the stock up...

If you are wondering whether LTC Properties at around US$38.99 is offering good value today, it helps to step back and look at what the recent share performance and fundamentals are really telling you. The stock has delivered a 0.6% return over the last week, a 1.0% decline over the past month, and is up 12.5% year to date and 15.5% over the past year, with longer term returns of 41.0% over three years and 26.1% over five years. Recent attention on LTC Properties has focused on its position...

Consolidated Edison recently entered into a new US$3.50 billions revolving credit facility to support its commercial paper programs and general corporate purposes, shortly after reporting Q4 2025 revenue and adjusted EPS that topped Wall Street expectations. Together with management’s plans for a five-year adjusted EPS compound annual growth rate of 6% to 7%, the expanded credit access highlights how the utility is prioritizing both liquidity and earnings visibility. We’ll now look at how...

Broadcom (AVGO) is in focus after a series of AI related announcements, including reports of rapid growth in AI semiconductor revenue, the introduction of the new Taurus 400G optical DSP and Tomahawk 6 switches, and new work on open optical standards. See our latest analysis for Broadcom. Even with all the AI headlines, Broadcom’s recent share price performance has cooled, with a 7 day share price return of a 6.02% decline and a 90 day share price return of a 4.80% decline, while the 1 year...

KE Holdings (NYSE:BEKE) FY 2025 Results Overview KE Holdings (NYSE:BEKE) has wrapped up FY 2025 with fourth quarter revenue of C¥22.2b and basic EPS of C¥0.08, alongside trailing 12 month revenue of C¥94.6b and basic EPS of C¥2.70 that frame the latest print for investors watching the stock around C¥16.90 per share. The company has seen quarterly revenue range from C¥22.1b to C¥26.0b over the past year, with basic EPS moving between C¥0.08 and C¥1.16 across FY 2025. This gives a clearer view...

OPAL Fuels (OPAL) has capped FY 2025 with fourth quarter revenue of US$99.8 million and basic EPS of US$0.08, setting a clean reference point for how its earnings story is developing. Over the past year, the company has seen quarterly revenue range from US$80.0 million to US$99.8 million and basic EPS move from a small loss of US$0.01 in Q1 2025 to positive readings in each subsequent quarter, giving you a clearer view of how the income line is tracking into year end. With trailing net profit...

ServiceNow (NOW) is back in focus after rolling out several AI powered products and partnerships across government, telecom, healthcare, and security, giving investors fresh context for assessing the software group’s recent volatility. See our latest analysis for ServiceNow. Despite this steady stream of AI partnerships and product launches across government, telecom, and healthcare, ServiceNow’s 30 day share price return of 7.28% sits against a 90 day share price return decline of 26.46% and...

Event context and recent performance Ellington Financial (EFC) has recently drawn attention after a period where the stock showed a return of about 1.2% over the past week, compared with weaker moves over the month and past 3 months. See our latest analysis for Ellington Financial. At a share price of $11.94, Ellington Financial has seen short term momentum soften, with a 30 day share price return of a 7.7% decline and a year to date share price return of a 12.7% decline. However, the 3 year...

Earlier this month, AbbVie reported positive Phase 1 multiple-ascending-dose results for its investigational obesity drug ABBV-295, a long-acting amylin analog that induced clinically meaningful, dose-dependent weight loss with generally mild gastrointestinal side effects over 12–13 weeks of treatment. The data highlight AbbVie’s push into a mechanistically distinct class of obesity therapies beyond incretin-based drugs, adding another potential pillar to its already broad pipeline in...

Wallenius Wilhelmsen (OB:WAWI) has renewed a contract with a global automotive distributor, covering an estimated net freight value of about US$190 million over a firm two year period with an optional third year. See our latest analysis for Wallenius Wilhelmsen. At a share price of NOK117.5, Wallenius Wilhelmsen has seen a 15.4% 90 day share price return and a very large 5 year total shareholder return. However, the sharp 12.6% 7 day share price pullback suggests some recent momentum has...

Zepp Health (ZEPP) has wrapped up FY 2025 with fourth quarter revenue of US$85.2 million and a basic EPS loss of US$0.69, setting the tone for how you might read the full year at the current share price of US$16.22. The company has seen quarterly revenue move from US$59.5 million in Q4 2024 to US$85.2 million in Q4 2025, while basic EPS over that stretch has shifted from a loss of US$2.29 to a loss of US$0.69. This puts the focus squarely on how sustainably margins can tighten those losses...

Woodside Energy Group (ASX:WDS) has moved the Trion Field project into its execution phase, starting a 24 well ultra deepwater drilling campaign in Mexico that is likely to sharpen investor focus on the stock. See our latest analysis for Woodside Energy Group. The Trion update and recent sustainability briefing come against a backdrop of strong momentum, with a 30 day share price return of 22.69% and a 1 year total shareholder return of 46.98%. If Trion has sharpened your interest in energy...